Whole-Genome Sequencing Comes of Age in Clinical Care

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.



 Already Registered? Click Here

In 2010, a team of geneticists and bioinformaticians at Medical College Wisconsin embarked on an ambitious clinical genome sequencing project to end the diagnostic odyssey of a young boy, Nicholas Volker. That project, led by Howard Jacob and Liz Worthey, successfully identified the single-base mutation responsible for Volker’s mystery autoimmune disease, resulting in a successful medical procedure. It became one of the signature events that signaled the potential of clinical genome sequencing.

Since then, clinical genome sequencing has benefited from continued improvements in DNA sequencing accuracy and throughput and genome interpretation software. Those improvements have made whole-genome sequencing an increasingly viable approach for precision diagnosis in clinical care (compared to exome sequencing).

In this Clinical OMICs KEYNOTE webinar, we are delighted to host two true pioneers of clinical genome sequencing, bioinformatician Dr. Liz Worthey and geneticist Dr. Howard Jacob, who will reflect on a decade of progress in clinical genome analysis and discuss the future challenges confronting the field. The former colleagues will offer complementary perspectives – Worthey as Associate Director of the Hugh Kaul Precision Medicine Institute at UAB, and Jacob as VP of Genomics Research at AbbVie, developing targeted therapeutics.

A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.


Liz Worthey, PhD
Director, Ctr Genomic
Data Sciences, Dept.
Pediatrics/Pathology, UAB
Birmingham, AL
View Biography
Howard Jacob, PhD
VP Genomics Research & VP Data Integration/
Convergence Distinguished Research Fellow, Abbvie
North Chicago, IL
View Biography